← Leaderboards
David L Veenstra
University Of Washington
$6,551,795
Attributed
$15,922,258
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,115,073 · 5
HHS (Other)$807,185 · 1
By mechanism
R01$7,146,217 · 2
U24$5,757,898 · 1
U01$2,189,580 · 1
U18$807,185 · 1
P01$21,378 · 1
Top collaborators
- Josh F. Peterson10 shared
- Jing Hao7 shared
- Stephanie Malia Fullerton6 shared
- Gail Pairitz Jarvik6 shared
- Deborah A Nickerson6 shared
- Peter Tarczy-Hornoch6 shared
- Susan Snyder3 shared
Most similar at University Of Washington
Same institution · by research overlap
- Wayne J Katon$13,355,662
- Donna L. Berry$7,674,074
- Nancy B. Kiviat$21,349,193
- Kenneth E. Thummel$18,445,737
- Samuel I. Miller$34,128,042
Others in their field
Top investigators on “Genomics”
- Eric S Lander · Whitehead Institute For Biomedical Res$790,826,794
- Richard A Gibbs · Baylor College Of Medicine$661,700,875
- Richard K. Wilson · Washington University$497,388,134
- Leonard Freedman · Leidos Biomedical Research, Inc.$405,398,682
- David Heimbrook · Leidos Biomedical Research, Inc.$333,649,126
- Stacey Gabriel · Massachusetts Institute Of Technology$331,896,891
Research focus
GenomicsInvestmentsCaringBaseClinical CareExome SequencingEconomicsUncertaintyHealth EconomicsProgramsTechnologyFoundationsGenome SequencingUnited States National Institutes Of HealthAreaNovel StrategiesLiteratureHealthcare SystemsDecision MakingAdoptionProviderHealthcarePoliciesClinical Sequencing
Grant awards (26)
Rational Integration of Polygenic Risk Scores (RIPS)$878,824
R01 · FY2025 · HG
Rational Integration of Polygenic Risk Scores (RIPS)$903,936
R01 · FY2024 · HG
Rational Integration of Polygenic Risk Scores (RIPS)$955,275
R01 · FY2023 · HG
Rational Integration of Polygenic Risk Scores (RIPS)$999,221
R01 · FY2022 · HG
Evolving Our Partnership: The CSER2 Centralized Support Coordinating Center$925,210
U24 · FY2021 · HG
Evolving Our Partnership: The CSER2 Centralized Support Coordinating Center$1,435,576
U24 · FY2020 · HG
Rational Integration of clinical SEquencing (RISE)$709,835
R01 · FY2020 · HG
Evolving Our Partnership: The CSER2 Centralized Support Coordinating Center$989,655
U24 · FY2019 · HG
Rational Integration of clinical SEquencing (RISE)$710,081
R01 · FY2019 · HG
Evolving Our Partnership: The CSER2 Centralized Support Coordinating Center$445,921
U24 · FY2019 · HG
Genomics in Health and Wellness Employer Consortium$376,782
R01 · FY2019 · HG
Rational Integration of clinical SEquencing (RISE) - Administrative Supplement for Genomics in Health and Wellness Meeting$125,000
R01 · FY2019 · HG
Evolving Our Partnership: The CSER2 Centralized Support Coordinating Center$984,497
U24 · FY2018 · HG
Rational Integration of clinical SEquencing (RISE)$710,323
R01 · FY2018 · HG
Evolving Our Partnership: The CSER2 Centralized Support Coordinating Center$977,039
U24 · FY2017 · HG
Rational Integration of clinical SEquencing (RISE)$776,940
R01 · FY2017 · HG
Personalized Medicine Economics Research PriMER$355,874
U01 · FY2017 · AG · contact PI
Personalized Medicine Economics Research PriMER$508,915
U01 · FY2016 · AG · contact PI
Influence of vitamin K intake and genomics on clotting risk in warfarin treated patients$21,378
P01 · FY2016 · GM · contact PI
Personalized Medicine Economics Research PriMER$395,741
U01 · FY2015 · AG · contact PI
Health Economics Common Fund Program$145,828
U01 · FY2015 · AG · contact PI
Personalized Medicine Economics Research PriMER$370,176
U01 · FY2014 · AG · contact PI
Personalized Medicine Economics Research PriMER$413,046
U01 · FY2013 · AG · contact PI
Risk-Benefit Framework for Genetic Tests$323,950
U18 · FY2010 · GD · contact PI
Risk-Benefit Framework for Genetic Tests$244,445
U18 · FY2009 · GD · contact PI
Risk-Benefit Framework for Genetic Tests$238,790
U18 · FY2008 · GD · contact PI